Shares of Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) ended Thursday session in green amid volatile trading. The shares closed up +0.51 points or 1.01% at $50.90 with 7.27 million shares getting traded. Post opening the session at $50.18, the shares hit an intraday low of $50.15 and an intraday high of $51.21 and the price vacillated in this range throughout the day. The company has a market cap of $51.64 billion and the numbers of outstanding shares have been calculated to be 1.01 billion shares.
Teva Pharmaceutical Industries Ltd (ADR) (TEVA) announced that five company-sponsored abstracts will be presented at the 2016 European Respiratory Society (ERS) International Congress in London, England on September 3-7, 2016.
The presentations include new data on Teva’s biologic CINQAERO® for severe eosinophilic asthma and the health economic impact of severe eosinophilic asthma. Of note, one of the abstracts will present a new analysis of CINQAERO® among the Global Initiative for Asthma (GINA) Step 4 and Step 5 patient groups.
“The European Respiratory Society (ERS) International Congress provides Teva with a tremendous opportunity to showcase the technological and therapeutic advancements our team continues to develop for patients around the world living with respiratory disease,” said Tushar Shah, MD, Senior Vice President, Teva Global Respiratory Research and Development. “This year we will present data from both our inhaler and biologics portfolios to showcase our commitment to the respiratory community as a core therapeutic area for Teva. We are particularly pleased that a new analysis of our CINQAERO® pivotal data will be highlighted at the meeting, examining its clinical efficacy in patients categorized by GINA Step 4 and 5 levels of asthma severity.”
Shares of Inovio Pharmaceuticals Inc (NASDAQ:INO) ended Thursday session in red amid volatile trading. The shares closed down -0.03 points or -0.33% at $9.14 with 1.01 million shares getting traded. Post opening the session at $9.12, the shares hit an intraday low of $9.01 and an intraday high of $9.27 and the price vacillated in this range throughout the day. The company has a market cap of $652.31 million and the numbers of outstanding shares have been calculated to be 73.55 million shares.
Inovio Pharmaceuticals Inc (INO) announced that it will present a corporate overview at the following upcoming conferences:
Citi 11th Annual Biotech Conference
Mandarin Oriental, Boston, Thursday, September 8th, 1×1 meetings
23rd Annual Newsmakers in the Biotech Industry
Millennium Broadway Hotel, New York, Friday, September 9th, 11:00 am ET
Rodman & Renshaw 18th Annual Global Investment Conference
Lotte New York Palace Hotel, New York, Monday, September 12th, 2:35 pm ET
A live and archived version of the Rodman & Renshaw presentation delivered by Inovio’s CEO, Dr. J. Joseph Kim, will be available through the “Webcast” tab on Inovio’s home page at www.inovio.com as well as at the following URL: http://wsw.com/webcast/rrshq26/ino.